Pfizer to Slash COVID-19 Vaccine Manufacturing Time by Almost 50 Percent
XTalks
FEBRUARY 11, 2021
Amidst growing global shortages of COVID-19 vaccine supplies, inaugural (by way of authorizations/approvals) COVID-19 vaccine maker Pfizer is addressing the issue by working to cut the manufacturing time of its vaccine by almost half. Related: Pharma Rivals Step Up to Assist with COVID-19 Vaccine Production.
Let's personalize your content